Anti proliferative preparations
AssigneeI.B.R. Israeli Biotechnology Research Ltd.
InventorsEtienne Soudant, Lea Bezalel, Meira Ziv, Inon Perry
Life of this patent
Estimating the term…
Abstract
A dormant preparation (DC) is provided which is capable of inhibiting proliferation of various kinds of cells. The preparation comprises an extract which is obtained from cells or tissue originating in an organism capable of entering a phase of dormancy in at least one of its parts and comprises at least one substance which induces or maintains the state of dormancy in the organism from which the cells or tissue are derived. The DC may be used for a variety of indications including human medicine and cosmetics, plant growth control and food preservation.
Claims4
A process for producing a purified dorman water extract which inhibits proliferation of target cells or target tissue in diseases and conditions selected from the group consisting of carcinoma, psoriasis, seborrheic keratosis, and wart and/or papilloma infection, comprising:
- (a) providing producer cells or producer tissue which is derived from an organism which is zenogeneic to said target cells or target tissue and which is capable of entering into a dormant state, wherein said organism is a plant selected from the group consisting of Narcissus, Hyacinth carnegie, Amaryllis, and Pancratium;
- (b) inducing said producer cells or producer tissue to enter a dormant state using high temperature, humidity, or combination thereof, or if already in a dormant state, maintaining said state;
- and
- (c) conducting a water extraction from the dormant producer cells, dormant producer tissue or from a medium in which said dormant cells or dormant tissue were incubated to obtain a water-soluble dorman extract, whereby, the extract is fractionated so as to obtain a purified dorman extract which is capable of passing through a 0.45 μm filter from said dormant producer cells or dormant producer tissue or from a medium in which said dormant cells or tissue was incubated, and whereby, the extract displays a reversible cell anti-proliferative activity without substantial cytotoxicity, wherein the activity is substantially higher in said fraction than the same fraction obtained from said producer cells or tissue, when in a non-dormant state.
Dependencies are inferred from the claim text.